NeurOdys Therapeutics
PrivateLast Round
Pre Seed
Mar 15, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
NeurOdys Therapeutics operates in Healthcare & Life Sciences and is based in Amsterdam. Its latest recorded funding round was a Pre Seed round in March 2026.
NeurOdys Therapeutics is a biotechnology company developing small molecule therapies for neurodegenerative disorders such as Alzheimer's and Parkinson's diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeurOdys Therapeutics Comparables
Compare NeurOdys Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mair Therapeutics | 90% | |
| Polku Therapeutics | 78% | |
| SciNeuro | 76% |
For institutional investors. Book with your work email.
NeurOdys Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
NeurOdys Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Expert Systems Inc. | Pre Seed |
| Torrey Pines Investment LLC | Pre Seed |
| Rambam AG | Pre Seed |
| NLC Health Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 15, 2026
Led by NLC Health Ventures and Rambam AG.
For institutional investors. Book with your work email.
NeurOdys Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NeurOdys Therapeutics's valuation, stock price, and market status.
Is NeurOdys Therapeutics a public or private company?
NeurOdys Therapeutics is a private company.
What is the current stock price of NeurOdys Therapeutics?
NeurOdys Therapeutics is a private company, so its shares have no public market price. Caplight tracks NeurOdys Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NeurOdys Therapeutics worth (valuation)?
Valuation information for NeurOdys Therapeutics is not publicly available.
Can I buy NeurOdys Therapeutics stock?
NeurOdys Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NeurOdys Therapeutics's last funding round?
NeurOdys Therapeutics's most recent funding round was Pre Seed on March 15, 2026.
Who are the main investors in NeurOdys Therapeutics?
Key investors in NeurOdys Therapeutics include Rambam AG, NLC Health Ventures.
Will NeurOdys Therapeutics IPO soon?
No public IPO plans have been announced for NeurOdys Therapeutics.
How can I track NeurOdys Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in NeurOdys Therapeutics's shares on secondary markets.